{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:19:40Z","timestamp":1773213580857,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00993"],"award-info":[{"award-number":["PI18\/00993"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP16\/00097"],"award-info":[{"award-number":["CP16\/00097"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-106000RB-C22\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2019-106000RB-C22\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011596","name":"Conselleria d'Educaci\u00f3, Investigaci\u00f3, Cultura i Esport","doi-asserted-by":"publisher","award":["PROMETEO\/2019\/060"],"award-info":[{"award-number":["PROMETEO\/2019\/060"]}],"id":[{"id":"10.13039\/501100011596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011596","name":"Conselleria d'Educaci\u00f3, Investigaci\u00f3, Cultura i Esport","doi-asserted-by":"publisher","award":["ACIF\/2018\/0226"],"award-info":[{"award-number":["ACIF\/2018\/0226"]}],"id":[{"id":"10.13039\/501100011596","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00204-022-03236-y","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T02:02:20Z","timestamp":1644804140000},"page":"1021-1037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Oxidative-stress and long-term hepatotoxicity: comparative study in Upcyte human hepatocytes and hepaRG cells"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2532-790X","authenticated-orcid":false,"given":"M. Teresa","family":"Donato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Pelech\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1740-0874","authenticated-orcid":false,"given":"Laia","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"issue":"4","key":"3236_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/00002018-200730040-00001","volume":"30","author":"G Abboud","year":"2007","unstructured":"Abboud G, Kaplowitz N (2007) Drug-induced liver injury. Drug Saf 30(4):277\u2013294","journal-title":"Drug Saf"},{"issue":"6","key":"3236_CR2","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1002\/hep.24290","volume":"53","author":"S Antherieu","year":"2011","unstructured":"Antherieu S, Rogue A, Fromenty B, Guillouzo A, Robin MA (2011) Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in heparg cells. Hepatology 53(6):1895\u20131905. https:\/\/doi.org\/10.1002\/hep.24290","journal-title":"Hepatology"},{"issue":"1","key":"3236_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.taap.2013.11.022","volume":"275","author":"FA Atienzar","year":"2014","unstructured":"Atienzar FA, Novik EI, Gerets HH et al (2014) Predictivity of dog co-culture model, primary human hepatocytes and hepg2 cells for the detection of hepatotoxic drugs in humans. Toxicol Appl Pharmacol 275(1):44\u201361. https:\/\/doi.org\/10.1016\/j.taap.2013.11.022","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"3236_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/dmd.116.074369","volume":"45","author":"CC Bell","year":"2017","unstructured":"Bell CC, Lauschke VM, Vorrink SU et al (2017) Transcriptional, functional, and mechanistic comparisons of stem cell-derived hepatocytes, heparg cells, and three-dimensional human hepatocyte spheroids as predictive in vitro systems for drug-induced liver injury. Drug Metab Dispos 45(4):419\u2013429. https:\/\/doi.org\/10.1124\/dmd.116.074369","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3236_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/toxsci\/kfx289","volume":"162","author":"CC Bell","year":"2018","unstructured":"Bell CC, Dankers ACA, Lauschke VM et al (2018) Comparison of hepatic 2D sandwich cultures and 3D spheroids for long-term toxicity applications: a multicenter study. Toxicol Sci 162(2):655\u2013666. https:\/\/doi.org\/10.1093\/toxsci\/kfx289","journal-title":"Toxicol Sci"},{"issue":"1 Pt A","key":"3236_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tiv.2014.08.012","volume":"30","author":"JJ Broeders","year":"2015","unstructured":"Broeders JJ, Parmentier C, Truisi GL et al (2015) Biokinetics of chlorpromazine in primary rat and human hepatocytes and human heparg cells after repeated exposure. Toxicol In Vitro 30(1 Pt A):52\u201361. https:\/\/doi.org\/10.1016\/j.tiv.2014.08.012","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"3236_CR7","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/tox.22301","volume":"32","author":"S Bucher","year":"2017","unstructured":"Bucher S, Jalili P, Le Guillou D et al (2017) Bisphenol a induces steatosis in HepaRG cells using a model of perinatal exposure. Environ Toxicol 32(3):1024\u20131036. https:\/\/doi.org\/10.1002\/tox.22301","journal-title":"Environ Toxicol"},{"issue":"4","key":"3236_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1021\/acs.chemrestox.7b00025","volume":"30","author":"R Chan","year":"2017","unstructured":"Chan R, Benet LZ (2017) Evaluation of DILI predictive hypotheses in early drug development. Chem Res Toxicol 30(4):1017\u20131029. https:\/\/doi.org\/10.1021\/acs.chemrestox.7b00025","journal-title":"Chem Res Toxicol"},{"issue":"15\u201316","key":"3236_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.drudis.2011.05.007","volume":"16","author":"M Chen","year":"2011","unstructured":"Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W (2011) FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today 16(15\u201316):697\u2013703. https:\/\/doi.org\/10.1016\/j.drudis.2011.05.007","journal-title":"Drug Discov Today"},{"key":"3236_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10010106","author":"M Donato","year":"2021","unstructured":"Donato M, Tolosa L (2021) High-Content screening for the detection of drug-induced oxidative stress in liver cells. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox10010106","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"3236_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/138920008783331086","volume":"9","author":"MT Donato","year":"2008","unstructured":"Donato MT, Lahoz A, Castell JV, Gomez-Lechon MJ (2008) Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab 9(1):1\u201311","journal-title":"Curr Drug Metab"},{"issue":"6","key":"3236_CR13","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00216-009-3441-1","volume":"396","author":"MT Donato","year":"2010","unstructured":"Donato MT, Montero S, Castell JV, Gomez-Lechon MJ, Lahoz A (2010) Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies. Anal Bioanal Chem 396(6):2251\u20132263. https:\/\/doi.org\/10.1007\/s00216-009-3441-1","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"3236_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/1087057111427586","volume":"17","author":"MT Donato","year":"2012","unstructured":"Donato MT, Tolosa L, Jimenez N, Castell JV, Gomez-Lechon MJ (2012) High-content imaging technology for the evaluation of drug-induced steatosis using a multiparametric cell-based assay. J Biomol Screen 17(3):394\u2013400. https:\/\/doi.org\/10.1177\/1087057111427586","journal-title":"J Biomol Screen"},{"key":"3236_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-4939-2074-7_5","volume":"1250","author":"MT Donato","year":"2015","unstructured":"Donato MT, Tolosa L, Gomez-Lechon MJ (2015) Culture and functional characterization of human hepatoma hepg2 cells. Methods Mol Biol 1250:77\u201393. https:\/\/doi.org\/10.1007\/978-1-4939-2074-7_5","journal-title":"Methods Mol Biol"},{"issue":"12","key":"3236_CR16","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s00204-016-1845-1","volume":"90","author":"S Dragovic","year":"2016","unstructured":"Dragovic S, Vermeulen NP, Gerets HH et al (2016) Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man. Arch Toxicol 90(12):2979\u20133003. https:\/\/doi.org\/10.1007\/s00204-016-1845-1","journal-title":"Arch Toxicol"},{"issue":"1","key":"3236_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.18433\/j3sg66","volume":"11","author":"ME Elsherbiny","year":"2008","unstructured":"Elsherbiny ME, El-Kadi AO, Brocks DR (2008) The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole. J Pharm Pharmaceutical Sci 11(1):147\u2013159. https:\/\/doi.org\/10.18433\/j3sg66","journal-title":"J Pharm Pharmaceutical Sci"},{"issue":"6","key":"3236_CR18","first-page":"978","volume":"21","author":"G Fabre","year":"1993","unstructured":"Fabre G, Julian B, Saint-Aubert B, Joyeux H, Berger Y (1993) Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions. Drug Metab Dispos 21(6):978\u2013985","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"3236_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00204-016-1874-9","volume":"91","author":"C Funk","year":"2017","unstructured":"Funk C, Roth A (2017) Current limitations and future opportunities for prediction of DILI from in vitro. Arch Toxicol 91(1):131\u2013142. https:\/\/doi.org\/10.1007\/s00204-016-1874-9","journal-title":"Arch Toxicol"},{"issue":"10","key":"3236_CR20","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","volume":"94","author":"M Garcia-Cortes","year":"2020","unstructured":"Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ (2020) Drug induced liver injury: an update. Arch Toxicol 94(10):3381\u20133407. https:\/\/doi.org\/10.1007\/s00204-020-02885-1","journal-title":"Arch Toxicol"},{"issue":"2","key":"3236_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.tiv.2013.10.015","volume":"28","author":"H Garside","year":"2014","unstructured":"Garside H, Marcoe KF, Chesnut-Speelman J et al (2014) Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes. Toxicol In Vitro 28(2):171\u2013181. https:\/\/doi.org\/10.1016\/j.tiv.2013.10.015","journal-title":"Toxicol In Vitro"},{"key":"3236_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2014.05.009","author":"D Germano","year":"2014","unstructured":"Germano D, Uteng M, Pognan F, Chibout SD, Wolf A (2014) Determination of liver specific toxicities in rat hepatocytes by high content imaging during 2-week multiple treatment. Toxicol In Vitro. https:\/\/doi.org\/10.1016\/j.tiv.2014.05.009","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"3236_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2174\/1389200043335414","volume":"5","author":"MJ Gomez-Lechon","year":"2004","unstructured":"Gomez-Lechon MJ, Donato MT, Castell JV, Jover R (2004) Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr Drug Metab 5(5):443\u2013462","journal-title":"Curr Drug Metab"},{"issue":"6","key":"3236_CR24","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/jat.3277","volume":"36","author":"MJ Gomez-Lechon","year":"2016","unstructured":"Gomez-Lechon MJ, Tolosa L, Donato MT (2016) Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs. J Appl Toxicol 36(6):752\u2013768. https:\/\/doi.org\/10.1002\/jat.3277","journal-title":"J Appl Toxicol"},{"issue":"1","key":"3236_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/toxsci\/kft223","volume":"137","author":"F Gustafsson","year":"2014","unstructured":"Gustafsson F, Foster AJ, Sarda S, Bridgland-Taylor MH, Kenna JG (2014) A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans. Toxicol Sci 137(1):189\u2013211","journal-title":"Toxicol Sci"},{"issue":"1","key":"3236_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/toxsci\/kfx029","volume":"157","author":"P Haegler","year":"2017","unstructured":"Haegler P, Joerin L, Krahenbuhl S, Bouitbir J (2017) Hepatocellular toxicity of imidazole and triazole antimycotic agents. Toxicol Sci 157(1):183\u2013195. https:\/\/doi.org\/10.1093\/toxsci\/kfx029","journal-title":"Toxicol Sci"},{"issue":"7","key":"3236_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3109\/10408444.2013.811215","volume":"43","author":"M Hewitt","year":"2013","unstructured":"Hewitt M, Enoch SJ, Madden JC, Przybylak KR, Cronin MT (2013) Hepatotoxicity: a scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action. Crit Rev Toxicol 43(7):537\u2013558. https:\/\/doi.org\/10.3109\/10408444.2013.811215","journal-title":"Crit Rev Toxicol"},{"issue":"9","key":"3236_CR28","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1124\/dmd.116.069831","volume":"44","author":"JP Jackson","year":"2016","unstructured":"Jackson JP, Li L, Chamberlain ED, Wang H, Ferguson SS (2016) Contextualizing hepatocyte functionality of cryopreserved heparg cell cultures. Drug Metab Dispos 44(9):1463\u20131479. https:\/\/doi.org\/10.1124\/dmd.116.069831","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"3236_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1124\/dmd.107.017418","volume":"36","author":"KP Kanebratt","year":"2008","unstructured":"Kanebratt KP, Andersson TB (2008) HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans. Drug Metab Dispos 36(1):137\u2013145. https:\/\/doi.org\/10.1124\/dmd.107.017418","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3236_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/toxsci\/kfl096","volume":"94","author":"TK Kiang","year":"2006","unstructured":"Kiang TK, Ho PC, Anari MR, Tong V, Abbott FS, Chang TK (2006) Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1\/*1 genotype. Toxicol Sci 94(2):261\u2013271. https:\/\/doi.org\/10.1093\/toxsci\/kfl096","journal-title":"Toxicol Sci"},{"issue":"1 Pt A","key":"3236_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tiv.2015.09.005","volume":"30","author":"NI Kramer","year":"2015","unstructured":"Kramer NI, Di Consiglio E, Blaauboer BJ, Testai E (2015) Biokinetics in repeated-dosing in vitro drug toxicity studies. Toxicol In Vitro 30(1 Pt A):217\u201324. https:\/\/doi.org\/10.1016\/j.tiv.2015.09.005","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"3236_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/14740338.2017.1270264","volume":"16","author":"I Kyriakidis","year":"2017","unstructured":"Kyriakidis I, Tragiannidis A, Munchen S, Groll AH (2017) Clinical hepatotoxicity associated with antifungal agents. Expert Opin Drug Saf 16(2):149\u2013165. https:\/\/doi.org\/10.1080\/14740338.2017.1270264","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"3236_CR33","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.tiv.2007.03.022","volume":"21","author":"A Lahoz","year":"2007","unstructured":"Lahoz A, Donato MT, Picazo L, Gomez-Lechon MJ, Castell JV (2007) Determination of major human cytochrome P450s activities in 96-well plates using liquid chromatography tandem mass spectrometry. Toxicol In Vitro 21(7):1247\u20131252. https:\/\/doi.org\/10.1016\/j.tiv.2007.03.022","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"3236_CR34","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1056\/NEJMra021844","volume":"349","author":"WM Lee","year":"2003","unstructured":"Lee WM (2003) Drug-induced hepatotoxicity. N Engl J Med 349(5):474\u2013485","journal-title":"N Engl J Med"},{"key":"3236_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.11.026","volume":"78","author":"SB Leite","year":"2016","unstructured":"Leite SB, Roosens T, El Taghdouini A et al (2016) Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro. Biomaterials 78:1\u201310. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.11.026","journal-title":"Biomaterials"},{"issue":"1","key":"3236_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/toxsci\/kfs289","volume":"131","author":"J Lu","year":"2013","unstructured":"Lu J, Miyakawa K, Roth RA, Ganey PE (2013) Tumor necrosis factor-alpha potentiates the cytotoxicity of amiodarone in Hepa1c1c7 cells: roles of caspase activation and oxidative stress. Toxicol Sci 131(1):164\u2013178. https:\/\/doi.org\/10.1093\/toxsci\/kfs289","journal-title":"Toxicol Sci"},{"issue":"1","key":"3236_CR37","doi-asserted-by":"publisher","first-page":"e30014","DOI":"10.1371\/journal.pone.0030014","volume":"7","author":"M Moya","year":"2012","unstructured":"Moya M, Benet M, Guzman C et al (2012) Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver. PLoS ONE 7(1):e30014. https:\/\/doi.org\/10.1371\/journal.pone.0030014","journal-title":"PLoS ONE"},{"issue":"1","key":"3236_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tiv.2013.06.024","volume":"28","author":"D Mueller","year":"2014","unstructured":"Mueller D, Kramer L, Hoffmann E, Klein S, Noor F (2014) 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. Toxicol In Vitro 28(1):104\u2013112. https:\/\/doi.org\/10.1016\/j.tiv.2013.06.024","journal-title":"Toxicol In Vitro"},{"issue":"9","key":"3236_CR39","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00204-006-0091-3","volume":"80","author":"PJ O'Brien","year":"2006","unstructured":"O\u2019Brien PJ, Irwin W, Diaz D et al (2006) High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol 80(9):580\u2013604. https:\/\/doi.org\/10.1007\/s00204-006-0091-3","journal-title":"Arch Toxicol"},{"issue":"11","key":"3236_CR40","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/jcph.1444","volume":"59","author":"JW Park","year":"2019","unstructured":"Park JW, Kim KA, Park JY (2019) Effects of ketoconazole, a CYP4F2 inhibitor, and CYP4F2*3 genetic polymorphism on pharmacokinetics of vitamin K1. J Clin Pharmacol 59(11):1453\u20131461. https:\/\/doi.org\/10.1002\/jcph.1444","journal-title":"J Clin Pharmacol"},{"issue":"1 Pt A","key":"3236_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.tiv.2014.12.012","volume":"30","author":"G Pomponio","year":"2015","unstructured":"Pomponio G, Savary CC, Parmentier C et al (2015) In vitro kinetics of amiodarone and its major metabolite in two human liver cell models after acute and repeated treatments. Toxicol In Vitro 30(1 Pt A):36\u201351. https:\/\/doi.org\/10.1016\/j.tiv.2014.12.012","journal-title":"Toxicol In Vitro"},{"key":"3236_CR42","doi-asserted-by":"publisher","first-page":"2475631","DOI":"10.1155\/2016\/2475631","volume":"2016","author":"A Pradip","year":"2016","unstructured":"Pradip A, Steel D, Jacobsson S et al (2016) High Content analysis of human pluripotent stem cell derived hepatocytes reveals drug induced steatosis and phospholipidosis. Stem Cells Int 2016:2475631. https:\/\/doi.org\/10.1155\/2016\/2475631","journal-title":"Stem Cells Int"},{"key":"3236_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.tiv.2016.02.019","volume":"33","author":"J Saito","year":"2016","unstructured":"Saito J, Okamura A, Takeuchi K, Hanioka K, Okada A, Ohata T (2016) High content analysis assay for prediction of human hepatotoxicity in HepaRG and HepG2 cells. Toxicol in Vitro 33:63\u201370. https:\/\/doi.org\/10.1016\/j.tiv.2016.02.019","journal-title":"Toxicol in Vitro"},{"issue":"8","key":"3236_CR44","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.3390\/ph3082709","volume":"3","author":"J Saruwatari","year":"2010","unstructured":"Saruwatari J, Ishitsu T, Nakagawa K (2010) Update on the genetic polymorphisms of drug-metabolizing enzymes in antiepileptic drug therapy. Pharmaceuticals (basel) 3(8):2709\u20132732. https:\/\/doi.org\/10.3390\/ph3082709","journal-title":"Pharmaceuticals (basel)"},{"key":"3236_CR45","doi-asserted-by":"publisher","first-page":"626805","DOI":"10.3389\/fcell.2021.626805","volume":"9","author":"AS Serras","year":"2021","unstructured":"Serras AS, Rodrigues JS, Cipriano M, Rodrigues AV, Oliveira NG, Miranda JP (2021) A critical perspective on 3d liver models for drug metabolism and toxicology studies. Front Cell Dev Biol 9:626805. https:\/\/doi.org\/10.3389\/fcell.2021.626805","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"3236_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/toxsci\/kfv155","volume":"147","author":"A Sharanek","year":"2015","unstructured":"Sharanek A, Burban A, Humbert L et al (2015) Cellular accumulation and toxic effects of bile acids in cyclosporine a-treated heparg hepatocytes. Toxicol Sci 147(2):573\u2013587. https:\/\/doi.org\/10.1093\/toxsci\/kfv155","journal-title":"Toxicol Sci"},{"issue":"2","key":"3236_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","volume":"31","author":"MF Silva","year":"2008","unstructured":"Silva MF, Aires CC, Luis PB et al (2008) Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J Inherit Metab Dis 31(2):205\u2013216. https:\/\/doi.org\/10.1007\/s10545-008-0841-x","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"3236_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/toxsci\/kfv136","volume":"147","author":"RL Sison-Young","year":"2015","unstructured":"Sison-Young RL, Mitsa D, Jenkins RE et al (2015) Comparative proteomic characterization of 4 human liver-derived single cell culture models reveals significant variation in the capacity for drug disposition, bioactivation, and detoxication. Toxicol Sci 147(2):412\u2013424. https:\/\/doi.org\/10.1093\/toxsci\/kfv136","journal-title":"Toxicol Sci"},{"issue":"3","key":"3236_CR49","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00204-016-1745-4","volume":"91","author":"RL Sison-Young","year":"2017","unstructured":"Sison-Young RL, Lauschke VM, Johann E et al (2017) A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicity. Arch Toxicol 91(3):1385\u20131400. https:\/\/doi.org\/10.1007\/s00204-016-1745-4","journal-title":"Arch Toxicol"},{"issue":"2","key":"3236_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.toxlet.2015.03.011","volume":"235","author":"S Teng","year":"2015","unstructured":"Teng S, Barcellini-Couget S, Beaudouin R et al (2015) BK\/TD models for analyzing in vitro impedance data on cytotoxicity. Toxicol Lett 235(2):96\u2013106. https:\/\/doi.org\/10.1016\/j.toxlet.2015.03.011","journal-title":"Toxicol Lett"},{"issue":"8","key":"3236_CR51","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1021\/tx300091x","volume":"25","author":"RA Thompson","year":"2012","unstructured":"Thompson RA, Isin EM, Li Y et al (2012) In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs. Chem Res Toxicol 25(8):1616\u20131632. https:\/\/doi.org\/10.1021\/tx300091x","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"3236_CR52","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/toxsci\/kfs083","volume":"127","author":"L Tolosa","year":"2012","unstructured":"Tolosa L, Pinto S, Donato MT et al (2012) Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs. Toxicol Sci 127(1):187\u2013198. https:\/\/doi.org\/10.1093\/toxsci\/kfs083","journal-title":"Toxicol Sci"},{"issue":"10","key":"3236_CR53","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s00204-014-1334-3","volume":"89","author":"L Tolosa","year":"2015","unstructured":"Tolosa L, Carmona A, Castell JV, Gomez-Lechon MJ, Donato MT (2015) High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins. Arch Toxicol 89(10):1847\u20131860. https:\/\/doi.org\/10.1007\/s00204-014-1334-3","journal-title":"Arch Toxicol"},{"issue":"1","key":"3236_CR54","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/toxsci\/kfw078","volume":"152","author":"L Tolosa","year":"2016","unstructured":"Tolosa L, Gomez-Lechon MJ, Lopez S et al (2016) Human upcyte hepatocytes: characterization of the hepatic phenotype and evaluation for acute and long-term hepatotoxicity routine testing. Toxicol Sci 152(1):214\u2013229. https:\/\/doi.org\/10.1093\/toxsci\/kfw078","journal-title":"Toxicol Sci"},{"issue":"2","key":"3236_CR55","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00204-018-2349-y","volume":"93","author":"L Tolosa","year":"2019","unstructured":"Tolosa L, Jimenez N, Pelecha M, Castell JV, Gomez-Lechon MJ, Donato MT (2019) Long-term and mechanistic evaluation of drug-induced liver injury in upcyte human hepatocytes. Arch Toxicol 93(2):519\u2013532. https:\/\/doi.org\/10.1007\/s00204-018-2349-y","journal-title":"Arch Toxicol"},{"issue":"2","key":"3236_CR56","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/toxsci\/kfy058","volume":"163","author":"SU Vorrink","year":"2018","unstructured":"Vorrink SU, Zhou Y, Ingelman-Sundberg M, Lauschke VM (2018) Prediction of drug-induced hepatotoxicity using long-term stable primary hepatic 3D spheroid cultures in chemically defined conditions. Toxicol Sci 163(2):655\u2013665. https:\/\/doi.org\/10.1093\/toxsci\/kfy058","journal-title":"Toxicol Sci"},{"key":"3236_CR57","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.fct.2018.02.036","volume":"114","author":"J Waizenegger","year":"2018","unstructured":"Waizenegger J, Braeuning A, Templin M, Lampen A, Hessel-Pras S (2018) Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: single versus repeated exposure. Food Chem Toxicol 114:215\u2013226. https:\/\/doi.org\/10.1016\/j.fct.2018.02.036","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"3236_CR58","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00204-016-1686-y","volume":"91","author":"F Wewering","year":"2017","unstructured":"Wewering F, Jouy F, Wissenbach DK et al (2017) Characterization of chemical-induced sterile inflammation in vitro: application of the model compound ketoconazole in a human hepatic co-culture system. Arch Toxicol 91(2):799\u2013810. https:\/\/doi.org\/10.1007\/s00204-016-1686-y","journal-title":"Arch Toxicol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03236-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-022-03236-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03236-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T04:43:50Z","timestamp":1647319430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-022-03236-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["3236"],"URL":"https:\/\/doi.org\/10.1007\/s00204-022-03236-y","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"29 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Health Research Institute La Fe (IIS La Fe) (2016\/0226, date of approval 06\/06\/2017). Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}